No Data
No Data
Insider Sale: Director Jens Holstein Sells 5,000 Shares of Veracyte Inc (VCYT)
Veracyte, Inc.'s (NASDAQ:VCYT) Prospects Need A Boost To Lift Shares
Veracyte, Inc.'s (NASDAQ:VCYT) price-to-sales (or "P/S") ratio of 5.1x might make it look like a strong buy right now compared to the Biotechs industry in the United States, where around half of the
Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024
Veracyte, Inc. (NASDAQ:VCYT) announced today that it will release financial results for the second quarter of 2024 after the close of market on Tuesday, August 6, 2024. Company management will host a conference call and
Veracyte (VCYT) Stock Jumps 13.2%: Will It Continue to Soar?
Zacks.com Featured Highlights Veracyte, Steelcase and Applied Industrial
Strong Week for Veracyte (NASDAQ:VCYT) Shareholders Doesn't Alleviate Pain of Three-year Loss
As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand at stock picking, you risk returning less than the market. Unfortunately, that's
No Data